Jefferies Financial Group Begins Coverage on Rapport Therapeutics (NASDAQ:RAPP)
Jefferies Financial Group assumed coverage on shares of Rapport Therapeutics (NASDAQ:RAPP – Free Report) in a report released on Tuesday, Marketbeat.com reports. The firm issued a buy rating and a $35.00 price objective on the stock. Separately, Stifel Nicolaus started coverage on Rapport Therapeutics in a report on Tuesday. They set a buy rating and […]
More Stories
Oracle Power (LON:ORCP) Shares Down 14.3% – What’s Next?
Oracle Power plc (LON:ORCP – Get Free Report) shares dropped 14.3% during mid-day trading on Saturday . The company traded...
Arctic Star Exploration (CVE:ADD) Stock Price Up 50% – Here’s What Happened
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report)’s stock price was up 50% during mid-day trading on Saturday ....
Arctic Star Exploration (CVE:ADD) Stock Price Up 50% – Still a Buy?
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shares rose 50% on Saturday . The company traded as high...
PHX Minerals (NYSE:PHX) & EQT (NYSE:EQT) Financial Contrast
EQT (NYSE:EQT – Get Free Report) and PHX Minerals (NYSE:PHX – Get Free Report) are both oils/energy companies, but which...
Invesque (TSE:IVQ.U) Stock Price Up 20% – What’s Next?
Shares of Invesque Inc (TSE:IVQ.U – Get Free Report) were up 20% during mid-day trading on Saturday . The stock...
GGL Resources (CVE:GGL) Stock Price Up 33.3% – Should You Buy?
GGL Resources Corp. (CVE:GGL – Get Free Report)’s share price rose 33.3% during mid-day trading on Saturday . The stock...